Presentation of results from bioequivalence studies

Area of Science:

• Pharmacokinetics and Drug Development
• Clinical Trial Design and Analysis
• Pharmaceutical Regulatory Science

Background:

• Standardized presentation of bioequivalence study results is crucial for consistent interpretation and regulatory review.
• Existing guidelines offer general requirements but lack specific recommendations for result dissemination.
• Harmonizing the presentation of bioequivalence data facilitates peer review and scientific discourse.

Purpose of the Study:

• To propose standardized formats for presenting bioequivalence study results in both tabular and graphical forms.
• To differentiate between a comprehensive presentation suitable for research reports and a condensed version for publications.
• To improve the efficiency and quality of peer review for bioequivalence studies.

Main Methods:

• Development of specific recommendations based on general guidelines for bioequivalence study design and analysis.
• Illustration of recommendations using two examples: a single-dose and a multiple-dose study.
• Proposal of a standardized subset of essential results for publication.

Main Results:

• A detailed presentation format mirroring research report standards is provided.
• A concise, standardized subset of essential results for bioequivalence assessment is suggested for publication.
• Emphasis on including individual concentration/time data and calculation steps for comprehensive review.

Conclusions:

• Adopting the proposed standardized formats will enhance clarity and consistency in bioequivalence publications.
• A complete data presentation accompanying publications would significantly expedite peer review.
• The recommendations aim to improve and harmonize the overall standard of bioequivalence research dissemination.